- Home
- IGC vs SACH Comparison
IGC vs SACH Comparison
Compare IGC & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IGC | SACH |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 38.4M |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IGC | SACH |
|---|---|---|
| Price | $0.27 | $0.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.25 | $2.00 |
| AVG Volume (30 Days) | ★ 505.2K | 166.7K |
| Earning Date | 03-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | 59.09 | ★ 104.30 |
| EPS | ★ N/A | N/A |
| Revenue | $1,271,000.00 | ★ $57,500,000.00 |
| Revenue This Year | N/A | $145.00 |
| Revenue Next Year | $13.06 | $6.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.76 |
| 52 Week High | $0.45 | $1.45 |
Technical Indicators
Market Signals| Indicator | IGC | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 49.28 |
| Support Level | $0.27 | $0.91 |
| Resistance Level | $0.31 | $0.99 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 64.85 | 7.71 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.